Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparative study of the thymidine kinase and thymidylate kinase activities and of the feedbach inhibition of thymidine kinase in normal and neoplastic human tissue.

× No keyword cloud information.

9 in total

1. Thymidine kinase of mouse spleen cells in vivo and in vitro.

Authors: I Olsen; G Harris
Journal: Biochem J Date: 1975-02 Impact factor: 3.857

2. Serum thymidine kinase levels in cancer patients.

Authors: K L O'Neill; W P Abram; P G McKenna
Journal: Ir J Med Sci Date: 1986-08 Impact factor: 1.568

3. Effect of loss of thymidine kinase activity on the tumorigenicity of clones of SV40-transformed hamster cells.

Authors: H Rothschild; P H Black
Journal: Proc Natl Acad Sci U S A Date: 1970-10 Impact factor: 11.205

4. Potentiation of the antitumor activity of 5-trifluoromethyl-2'-deoxyuridine by the use of depot forms of the parent compound.

Authors: S Takeda; K Wierzba; J Yamashita; H Matsumoto; H Satake; Y Yamada; N Unemi; Y Wataya; H Hayatsu
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

5. Stabilization of SV40 transformed human fibroblast cytoplasmic thymidine kinase by ATP.

Authors: P N Porter; D Bull; O W Jones
Journal: Mol Cell Biochem Date: 1981-02-26 Impact factor: 3.396

6. The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.

Authors: J S Gronowitz; H Hagberg; C F Källander; B Simonsson
Journal: Br J Cancer Date: 1983-04 Impact factor: 7.640

Comparative study of the thymidine kinase and thymidylate kinase activities and of the feedbach inhibition of thymidine kinase in normal and neoplastic human tissue.

1. Thymidine kinase of mouse spleen cells in vivo and in vitro.

2. Serum thymidine kinase levels in cancer patients.

3. Effect of loss of thymidine kinase activity on the tumorigenicity of clones of SV40-transformed hamster cells.

4. Potentiation of the antitumor activity of 5-trifluoromethyl-2'-deoxyuridine by the use of depot forms of the parent compound.

5. Stabilization of SV40 transformed human fibroblast cytoplasmic thymidine kinase by ATP.

6. The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.

7. Cytotoxicity of trifluridine correlates with the thymidine kinase 1 expression level.

8. Thymidine kinase activities in mononuclear leukocytes and serum from breast cancer patients.

9. Cytofluorometric determination of thymidine kinase activity in a mixture of normal and neoplastic cells.